Insider · CIK 0001884308
Dennis Fehr
cfoofficer
Files at CGNX (COGNEX CORP). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | CGNX COGNEX CORP | MOption exercise Common Stock | +5,085 | $0.00 | $0 | 14,196 | Feb 19, 2026 |
| Feb 18, 2026 | CGNX COGNEX CORP | FTax withholding Common Stock | -1,618 | $56.72 | $92k | 12,578 | Feb 19, 2026 |
| Feb 17, 2026 | CGNX COGNEX CORP | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +25,306 | $0.00 | $0 | 25,306 | Feb 19, 2026 |
| Feb 18, 2026 | CGNX COGNEX CORP | MOption exercise Restricted Stock Unitderivative | -5,085 | $0.00 | $0 | 20,339 | Feb 19, 2026 |
| Feb 17, 2026 | CGNX COGNEX CORP | AGrant or award Restricted Stock Unitderivative | +24,523 | $0.00 | $0 | 24,523 | Feb 19, 2026 |
| May 6, 2025 | CGNX COGNEX CORP | MOption exercise Common Stock | +3,597 | $0.00 | $0 | 10,167 | May 7, 2025 |
| May 6, 2025 | CGNX COGNEX CORP | FTax withholding Common Stock | -1,056 | $27.83 | $29k | 9,111 | May 7, 2025 |
| May 6, 2025 | CGNX COGNEX CORP | MOption exercise Restricted Stock Unitderivative | -3,597 | $0.00 | $0 | 14,385 | May 7, 2025 |
| Feb 18, 2025 | CGNX COGNEX CORP | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +68,823 | $0.00 | $0 | 68,823 | Feb 20, 2025 |
| Feb 18, 2025 | CGNX COGNEX CORP | AGrant or award Restricted Stock Unitderivative | +25,424 | $0.00 | $0 | 25,424 | Feb 20, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.